AMG 609
Showing 1 - 25 of 370
Non-alcoholic Fatty Liver Disease Trial in United States (AMG 609, Placebo)
Recruiting
- Non-alcoholic Fatty Liver Disease
- AMG 609
- Placebo
-
Chandler, Arizona
- +9 more
Dec 28, 2022
Squamous-Cell Non-Small-Cell Lung Cancer Trial in Worldwide (Bemarituzumab, Docetaxel)
Recruiting
- Squamous-Cell Non-Small-Cell Lung Cancer
-
Orange, California
- +24 more
Jul 27, 2022
KRAS p, G12c Mutated /Advanced Metastatic NSCLC Trial in Worldwide (AMG 510, Docetaxel)
Active, not recruiting
- KRAS p, G12c Mutated /Advanced Metastatic NSCLC
- AMG 510
- Docetaxel
-
Anaheim, California
- +273 more
Nov 10, 2022
Relapsed/Refractory Multiple Myeloma Trial in Worldwide (AMG 701, Pomalidomide, Dexamethasone)
Active, not recruiting
- Relapsed/Refractory Multiple Myeloma
- AMG 701
- +2 more
-
Scottsdale, Arizona
- +33 more
Nov 29, 2022
Healthy Subjects Trial in Madison (AMG 510)
Completed
- Healthy Subjects
- AMG 510
-
Madison, WisconsinCovance Clinical Research Unit, Inc
Nov 3, 2022
Advanced Solid Tumors Trial in Worldwide (AMG 994, AMG 404)
Active, not recruiting
- Advanced Solid Tumors
- AMG 994
- AMG 404
-
Duarte, California
- +16 more
Nov 16, 2022
Healthy Volunteers Trial in Madison (AMG 510, Metformin)
Completed
- Healthy Volunteers
- AMG 510
- Metformin
-
Madison, WisconsinCovance Clinical Research Unit
Jan 9, 2023
MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors Trial (AMG 193, IDE397)
Not yet recruiting
- MTAP-null Non-Small-Cell Lung Cancer
- MTAP-null Solid Tumors
- AMG 193
- IDE397
- (no location specified)
Jul 27, 2023
Chronic Graft-versus-Host Disease (cGVHD) Trial in Randwick (AMG 592, Placebo)
Completed
- Chronic Graft-versus-Host Disease (cGVHD)
- AMG 592
- Placebo
-
Randwick, New South Wales, AustraliaResearch Site
May 23, 2023
Chronic Graft-versus-host Disease (cGVHD) Trial in Aventura (AMG 592, Placebo)
Completed
- Chronic Graft-versus-host Disease (cGVHD)
- AMG 592
- Placebo
-
Aventura, FloridaResearch Site
May 16, 2023
Heart Failure, Healthy Volunteer Trial in Worldwide (AMG 986 IV, AMG 986 PO, Placebo PO)
Terminated
- Heart Failure
- Healthy Volunteer
- AMG 986 IV
- +3 more
-
Anaheim, California
- +24 more
Mar 30, 2022
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)
Completed
- Advanced Malignancy
- +5 more
- AMG 820
-
Philadelphia, Pennsylvania
- +2 more
Jan 18, 2023
Acceleromyography- and Electromyography-based Neuromuscular
Not yet recruiting
- Neuromuscular Blockade
- TOF-Watch®;DELSYS® Wireless surface EMG
-
Wuhan, Hubei, ChinaDepartment of Anaesthesiology, Tongji Hospital of Tongji Medical
Dec 15, 2022
Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)
Completed
- Pancreatic Cancer
- +2 more
- AMG820 and pembrolizumab
-
Atlanta, Georgia
- +14 more
Jan 18, 2023
Vitiligo Trial in United States (AMG 714, Placebo, nbUVB phototherapy)
Recruiting
- Vitiligo
- AMG 714
- +2 more
-
Irvine, California
- +7 more
Dec 14, 2022
Small Cell Lung Carcinoma Trial in Worldwide (AMG 757, Pembrolizumab, CRS Mitigation Strategies)
Recruiting
- Small Cell Lung Carcinoma
- AMG 757
- +2 more
-
Duarte, California
- +34 more
Dec 6, 2022
Advanced Solid Tumors Trial in Worldwide (AMG 650)
Active, not recruiting
- Advanced Solid Tumors
- AMG 650
-
Los Angeles, California
- +21 more
Jan 26, 2023
Seroma of the Mammary Gland
Not yet recruiting
- Seroma
- +3 more
- Swap collection
- +2 more
- (no location specified)
Jun 1, 2023
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)
Completed
- Advanced Malignancy
- +5 more
- AMG 337
-
Los Angeles, California
- +7 more
Nov 3, 2022
Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, AMG 404, Dexamethasone Premedication)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- Blinatumomab
- +2 more
-
Duarte, California
- +18 more
Jul 27, 2022